Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT01057810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if asymptomatic or minimally symptomatic patients with metastatic prostate cancer who have not received chemotherapy live longer when treated with ipilimumab than those treated with a placebo
Study identification
- NCT ID
- NCT01057810
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 837 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2010 (Type not available)
- Primary completion
- Apr 2015 (Actual)
- Completion
- Jul 2015 (Actual)
- Last update posted
- Aug 18, 2016
2010 – 2015
United States locations
- U.S. sites
- 42
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Clinical Research Center, Llc | Anchorage | Alaska | 99508 | — |
| Pinnacle Oncology Hematology | Scottsdale | Arizona | 85258 | — |
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Desert Hematology Oncology | Rancho Mirage | California | 92270 | — |
| Southern California Permanente Medical Group | San Diego | California | 92108 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| Lynn Cancer Institute Center For Hematology-Oncology | Boca Raton | Florida | 33486 | — |
| Baptist Cancer Institute | Jacksonville | Florida | 32207 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Md Anderson Cancer Center Orlando | Orlando | Florida | 32806 | — |
| Hematology Oncology Associates Of The Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Northside Hospital | Atlanta | Georgia | 30341 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| Gwinnett Hospital System Inc. | Lawrenceville | Georgia | 30046 | — |
| Straub Clinic And Hospital | Honolulu | Hawaii | 96813 | — |
| University Of Chicago | Chicago | Illinois | 60637 | — |
| Cancer Care Specialists Of Central Illinois | Decatur | Illinois | 62526 | — |
| Goshen Center For Cancer Care | Goshen | Indiana | 46526 | — |
| Hutchinson Clinic, Pa | Hutchinson | Kansas | 67502 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| University Of Maryland | Baltimore | Maryland | 21201 | — |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Baltimore | Maryland | 21231 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Kansas City Veterans Affairs Medical Center | Kansas City | Missouri | 64128 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Comprehensive Cancer Centers Of Nevada | Las Vegas | Nevada | 89148 | — |
| North Shore Hematology/Oncology Associates, P.C. | East Setauket | New York | 11733 | — |
| Goshen Medical Associates | Goshen | New York | 10924 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794 | — |
| Suny Upstate Medical University | Syracuse | New York | 13210 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Novant Health Oncology Specialists | Winston-Salem | North Carolina | 27103 | — |
| Tulsa Cancer Institute | Tulsa | Oklahoma | 74136 | — |
| Kaiser Permanente Oncology/Hematology | Portland | Oregon | 97227 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| St. Luke'S Hospital & Health Network Laboratory | Bethlehem | Pennsylvania | 18015 | — |
| Cancer Center Of The Carolinas | Greenville | South Carolina | 29615 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Scott & White Memorial Hospital And Clinic | Temple | Texas | 76508 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Providence Regional Medical Center Everett | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01057810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2016 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01057810 live on ClinicalTrials.gov.